Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).

@article{Klaassen2012PilotSO,
  title={Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).},
  author={Robert J. Klaassen and Susan D. Mathias and George Buchanan and J. J. M. Van Bussel and Robert Deuson and Nancy L Young and Anderson B. Collier and Lisa R. Bomgaars and Victor S. Blanchette},
  journal={Pediatric blood & cancer},
  year={2012},
  volume={58 3},
  pages={395-8}
}
BACKGROUND Childhood ITP can have a negative impact on the child and his/her family even though it is typically a benign disorder with low risk of serious bleeding. In adults and now children, romiplostim increases the platelet count without significant adverse effects. In this study, the impact of romiplostim treatment on the HRQoL of children with chronic ITP was assessed using the Kid's ITP Tools (KIT). PROCEDURE Subjects 1-18 years old, with chronic ITP (>6 months), were enrolled in a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…